The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.
This review critically evaluates cbd topical pain safety in managing osteoarthritis symptoms. It highlights clinical evidence supporting cannabis-based medicinal products for symptom relief. The review also discusses future directions for research and…
Stop chasing THC percentages — the strongest weed isn’t always the best high. Mid-range THC + the right terpenes can hit
Cannabinoid potency is only half the story, the terpenoid profile and individual receptor sensitivity determine actual clinical outcomes. A well-balanced cultivar at 15-18% THC with optimal myrcene and limonene ratios often outperforms a 30% THC dominant…
New York Approves Cannabis for Anxiety Despite Mixed Science
New York cannabis anxiety approval marks a significant policy change. However, clinical evidence for cannabis treating anxiety remains limited and mixed. Patients and clinicians face challenges navigating this new approval.
CED News Digest: August 2026 Cannabis Highlights
This cannabis news digest August 2026 covers the latest developments in the cannabis industry. It highlights regulatory updates, market trends, and important news items. Stay informed with this focused cannabis news digest August 2026.
Yale and McGill Collaborate to Expand Cannabis Research
Academic partnerships cannabis research is growing with Yale and McGill's new collaboration. This effort aims to enhance clinical cannabis studies and infrastructure. The partnership promises to accelerate evidence-based protocols for clinicians.
Hemp Industry Hires More Help Amid Regulatory Battles
The hemp industry lobbying efforts are intensifying as regulatory uncertainty grows around hemp-derived THC products. These efforts influence federal policy and impact patient access to these products. Clinicians must understand these dynamics to guide…
Study Highlights Misleading Labels on Delta-8 Products | Cannabis Sciences – Labroots
Recent research reveals significant delta-8 product labeling inaccuracies that affect patient safety and dosing reliability. These misleading labels complicate clinical counseling and risk assessment. Clinicians should prioritize products with…
Bill Regulating THC Edible Sales in SC Nears Gov. McMaster’s Desk
South Carolina THC edible regulation is advancing toward gubernatorial approval, promising clearer standards for product quality and dosing. This legislation will help clinicians better counsel patients on safe cannabis edible use. Improved regulation…
Minnesota Officials Recall Tidal Wave THC Vapes for Safety Concerns
Minnesota officials have issued a tidal wave vape recall due to high THC content exceeding legal limits. This recall highlights safety concerns for patients using cannabis vapes with unexpected potency. Clinicians should be aware of these risks and…
Ohio Enforces Ban on Intoxicating Hemp-Derived THC Beverages
Ohio has implemented a hemp-derived THC beverages ban affecting intoxicating hemp product availability. Clinicians must counsel patients on this regulatory change and its impact on cannabis access. The hemp-derived THC beverages ban directs patients…
